A judge has ordered directors of collapsed mining company Termite Resources to pay $7 million in damages after finding they breached their duty by distributing more than $46 million to its parent company and failing to maintain a cash reserve of at least $10 million.
Generic pharmaceutical firm Sandoz has won a temporary stay of a $26.3 million judgment in a patent case as it awaits a decision by the Commissioner of Patents regarding a licence to make a cheaper version of the bestselling antidepressant Lexapro.
Deloitte Touche Tohmatsu is facing claims by the lead applicants in two class actions against failed retail giant Dick Smith alleging its poor accounting practices contributed to the retailer’s collapse.
Legal action brought by the corporate regulator over withheld documents at the centre of an investigation into AMP’s fees for no service conduct has settled, with law firm Clayton Utz producing the evidence on Thursday.
The Australian Competititon and Consumer Commission is investigating the proposed $231 million acquisition of Origin Energy’s Ironbark gas project in Queensland to Australia Pacific LNG.
KPMG has snagged heavy-hitters from Norton Rose Fulbright, Clayton Utz and Herbert Smith Freehills for its growing legal services team, adding strength to its financial services regulation, technology and telecom transactions, and government offerings.
Danish pharmaceutical giant Lundbeck secured $51.7 million in settlements to end infringement litigation with three generic makers over its patent for the top-selling Lexapro, the company has revealed.
Global insurer Jardine Lloyd Thompson has won access to the identities of local councils suing it in a NSW class action brought by Quinn Emanuel alleging the broker charged the councils excessive premiums.
The Full Court of the Federal Court has shot down a bid by the Victorian Government to intervene a second time in a long-running bargaining dispute between Esso Australia and three key Australian unions over its Bass Strait offshore oil and gas operations.
Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant Lexapro, a judge has found.